Sorafenib plus long-acting octreotide in advanced hepatocellular carcinoma. Preliminary results of a multicenter ongoing study

S. Del Prete; R. Addeo; L. Maiorino; G. Cennamo; V. Montesarchio; L. Leo; V. Faiola; R. Guarrasi; L. Tarantino; A. Vascone; A. D’Agostino; G. Palmieri; M. Bianco; M. Caraglia; C. Pizza; R. Mamone; L. Montella

首页> 外文期刊>European Journal of Cancer Supplements >Sorafenib plus long-acting octreotide in advanced hepatocellular carcinoma. Preliminary results of a multicenter ongoing study

【24h】

Sorafenib plus long-acting octreotide in advanced hepatocellular carcinoma. Preliminary results of a multicenter ongoing study

机译：索拉非尼加长效奥曲肽治疗晚期肝细胞癌。正在进行的多中心研究的初步结果

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《European Journal of Cancer Supplements》 |2008年第14期|共2页
作者
S. Del Prete; R. Addeo; L. Maiorino; G. Cennamo; V. Montesarchio; L. Leo; V. Faiola; R. Guarrasi; L. Tarantino; A. Vascone; A. D’Agostino; G. Palmieri; M. Bianco; M. Caraglia; C. Pizza; R. Mamone; L. Montella;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. SORAFENIB PLUS LONG-ACTING OCTREOTIDE IN ADVANCED HEPATOCELLULAR CARCINOMA. PRELIMINARY RESULTS OF A MULTICENTER ONGOING STUDY [J] . S.Del Prete, R. Addeo, L. Maiorino European Journal of Cancer Supplements . 2008,第14期

机译：晚期肝细胞癌中的索拉非尼加长效奥曲肽。多中心正在进行的研究的初步结果
2. Sorafenib plus octreotide is an effective and safe treatment in advanced hepatocellular carcinoma: multicenter phase II So.LAR. study. [J] . Prete SD, Montella L, Caraglia M, Cancer chemotherapy and pharmacology. . 2010,第5期

机译：索拉非尼加奥曲肽是晚期肝细胞癌的有效且安全的治疗方法：多中心II期So.LAR。研究。
3. Sorafenib plus octreotide is an effective and safe treatment in advanced hepatocellular carcinoma: multicenter phase II So.LAR. study [J] . Salvatore Del Prete, Liliana Montella, Michele Caraglia, Cancer Chemotherapy and Pharmacology . 2010,第5期

机译：索拉非尼加奥曲肽是晚期肝细胞癌的有效且安全的治疗方法：多中心II期So.LAR。研究
4. Diffusion-weighted MR imaging of advanced hepatocellular carcinoma treated with the oral multikinase inhibitor Sorafenib [C] . C. Schraml, N.F. Schwenzer, H. Rempp, World congress on medical physics and biomedical engineering;International congress of the IUPESM . 2011

机译：口服多激酶抑制剂索拉非尼治疗晚期肝癌的扩散加权MR成像
5. Poly(lactide-co-glycolide) Microspheres for Localized, Magnetic Resonance Imaging Monitored, Transcatheter Delivery of Sorafenib to Hepatocellular Carcinoma. [D] . Chen, Jeane. 2015

机译：聚（丙交酯-共-乙交酯）微球体用于局部监测，磁共振成像监测，索拉非尼经导管输送至肝细胞癌。
6. A Phase II Study of Long-Acting Octreotide in Patients With Advanced Hepatocellular Carcinoma and CLIP Score of 3 or Higher [O] . Usman Shah, Bert O’Neil, Jill Allen, 2009

机译：长效奥曲肽治疗晚期肝细胞癌且CLIP评分为3或更高的患者的II期研究
7. Sorafenib plus long-acting octreotide in advanced hepatocellular carcinoma. Preliminary results of a multicenter ongoing study [O] . Del Prete S., Addeo R., Maiorino L., 2008

机译：索拉非尼加长效奥曲肽治疗晚期肝细胞癌。正在进行的多中心研究的初步结果

Sorafenib plus long-acting octreotide in advanced hepatocellular carcinoma. Preliminary results of a multicenter ongoing study

著录项

相似文献

相关主题

期刊订阅